Davis Investment Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Sell
3,783
-7,139
-65% -$522K 0.08% 155
2026
Q1
$834K Buy
10,922
+4,024
+58% +$290K 0.29% 62
2025
Q4
$444K Sell
6,898
-124
-2% -$7.64K 0.16% 109
2025
Q3
$435K Sell
7,022
-495
-7% -$34.5K 0.15% 110
2025
Q2
$588K Buy
7,517
+46
+0.6% +$3.62K 0.21% 90
2025
Q1
$593K Buy
+7,471
New +$705K 0.26% 72
2023
Q1
Sell
-7,241
Closed -$641K 110
2022
Q4
$641K Buy
+7,241
New +$583K 0.32% 58

Other funds holding EMN

Davis Investment Partners's EMN Position: Q2 2026 in Review

Davis Investment Partners reduced its Eastman Chemical (EMN) stake by 65% in Q2 2026, selling an estimated $522K and leaving 3,783 shares worth $253K. The position accounts for 0.08% of the portfolio, ranked #155.

Davis Investment Partners first reported a position in EMN in Q4 2022 and has held it in 7 quarters since. The position peaked at $834K in Q1 2026. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Davis Investment Partners held 3,783 shares of Eastman Chemical worth $253K as of Q2 2026.
  • Davis Investment Partners sold 7,139 Eastman Chemical shares in Q2 2026, an estimated $522K.
  • Eastman Chemical made up 0.08% of Davis Investment Partners's portfolio in Q2 2026, its #155 holding.
  • Davis Investment Partners first reported a position in Eastman Chemical in Q4 2022 and has held it in 7 quarters since.
  • Davis Investment Partners's Eastman Chemical position peaked at $834K in Q1 2026.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.